Comanche Biopharma: Funding, Investors & Team (Oct 2026)
Comanche Biopharma is a biopharmaceutical company focused on creating siRNA therapy specifically designed to address preeclampsia. The objective of the company is to minimize the dangers associated with pregnancy and premature birth, enabling a safe and healthy progression of natural pregnancies while ensuring the proper development of the fetus.
Comanche Biopharma has raised $111M across 2 funding rounds on record, the most recent a Series B of $75.0M announced in Jan 2024.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Comanche Biopharma Company Profile and Key Stats
Latest funding round on record: Jan 2024.
Comanche Biopharma Funding Rounds
Comanche Biopharma raised $36.1M in an undisclosed round announced in May 2023.
8 months later, a Series B of $75.0M was announced in Jan 2024.
Comanche Biopharma Founders and Leadership Team
Contact details for the Comanche Biopharma team: 1 of 1 has an email address on file.
Start 14-day free trial →Comanche Biopharma Funding Compared to Other Biotechnology Startups
Comanche Biopharma's latest round of $75.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Comanche Biopharma in Biotechnology and Concord
Companies Similar to Comanche Biopharma
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Comanche Biopharma Funding FAQs
What does Comanche Biopharma do?
Comanche Biopharma is a biopharmaceutical company focused on creating siRNA therapy specifically designed to address preeclampsia. The objective of the company is to minimize the dangers associated with pregnancy and premature birth, enabling a safe and healthy progression of natural pregnancies while ensuring the proper development of the fetus.
How much funding has Comanche Biopharma raised?
Comanche Biopharma has raised $111M across 2 rounds on record. The most recent is a Series B of $75.0M announced in Jan 2024.
When did Comanche Biopharma last raise funding?
Comanche Biopharma's most recent funding round on record is a Series B of $75.0M, announced in Jan 2024.
Who founded Comanche Biopharma?
FundedIQ lists Mike Young (Founder) at Comanche Biopharma.
Where is Comanche Biopharma headquartered?
Comanche Biopharma is based in Concord, Massachusetts, United States.
How many employees does Comanche Biopharma have?
Comanche Biopharma is in the 11-50 employee band.
How does Comanche Biopharma's funding compare to other Biotechnology startups?
Comanche Biopharma's latest round of $75.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Comanche Biopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Comanche Biopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.